Thrombosis Update/X
Jun 15, 2025, 09:32
Silent Threat: Underrated Risk of Thrombosis in IBD Outpatients Revealed by New Data – Thrombosis Update
Thrombosis Update has presented new developments in its recent issue on X:
“New study in ThrombUpdate reveals a significant, often underestimated, risk of blood clots in IBD out-patients. They auhtors found 7.6% experienced a thromboembolic event in IBD patients.”
Title: Venous and arterial thromboembolism in out-patients with inflammatory bowel disease: a single center study
Autors: Antonella Tufano, Anna Testa, Marta Patturelli, Antonio Rispo, Vincenzo Fotticchia, Paola Rufolo, Federica Strano, Alessia Dalila Guarino, Antonietta Vitale, Olga Maria Nardone, Mario Ferrante, Rossella Caso, Fabiana Castiglione.
A new study published in Thrombosis Update highlights a significant and often underrecognized risk of thromboembolic events among outpatients with inflammatory bowel disease (IBD).
For more detailed insights, visit Hemostasis Today.
Alessia Dalila Guarino
American Society of Hematology
American Thrombosis and Hemostasis Network
Anna Testa
Antonella Tufano
Antonietta Vitale
Antonio Rispo
Clinical Implications
Fabiana Castiglione
Federica Strano
Hematology
Hemostasis
Hemostasis Today
Inflammatory Bowel Disease (IBD)
International Society on Thrombosis and Haemostasis (ISTH)
Mario Ferrante
Marta Patturelli
New Data-Thrombosis Update
Olga Maria Nardone
Outpatients
Paola Rufolo
Real-world Data
Risk Stratification
Rossella Caso
Thromboembolic Events
thrombosis
Thrombosis Update
TruJournal
Underrated Risk of Thrombosis
Vincenzo Fotticchia
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals
Sep 29, 2025, 12:54
Sep 29, 2025, 12:33
Sep 29, 2025, 06:23
Sep 29, 2025, 05:06
Sep 29, 2025, 04:28